Home > Riviste > The Journal of Cardiovascular Surgery > Fascicoli precedenti > The Journal of Cardiovascular Surgery 2017 August;58(4) > The Journal of Cardiovascular Surgery 2017 August;58(4):508-17

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

 

REVIEW  RECENT DEVELOPMENTS IN THE MANAGEMENT OF IN-STENT RESTENOSIS 

The Journal of Cardiovascular Surgery 2017 August;58(4):508-17

DOI: 10.23736/S0021-9509.17.09953-0

Copyright © 2017 EDIZIONI MINERVA MEDICA

lingua: Inglese

In-stent restenosis management: the best is yet to come

Jos C., van den BERG 1, 2

1 Universitätsinstitut für Diagnostische, Interventionelle und Pädiatrische Radiologie, Inselspital, Bern, Switzerland; 2 Centro Vascolare Ticino, Ospedale Regionale di Lugano, Lugano, Switzerland


PDF


The use of drug-eluting stents and of drug-coated balloons have mitigated the prevalence of in-stent restenosis, however in-stent remains a problem that continues to affect the long-term outcomes of femoro-popliteal endovascular therapy. This paper will provide an overview on the latest data with regard to the treatment of femoro-popliteal in-stent restenosis.


KEY WORDS: Femoral artery - Vascular graft occlusion - Drug-eluting stents - Balloon angioplasty

inizio pagina